LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 6.06 | 84.90 | 725 | 365 | 1.9838 | 1.7689 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 7.77 | 84.90 | 793 | 411 | 1.9283 | 1.6688 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 7.77 | 84.90 | 781 | 411 | 1.8991 | 1.6510 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 9.47 | 84.90 | 828 | 447 | 1.8506 | 1.5853 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 9.47 | 84.90 | 845 | 447 | 1.8886 | 1.6073 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 11.18 | 84.90 | 5 | 492 | 0.0102 | -0.6727 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 11.18 | 84.90 | 894 | 492 | 1.8158 | 1.5304 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 11.18 | 84.90 | 898 | 492 | 1.8239 | 1.5348 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.88 | 84.90 | 47 | 531 | 0.0885 | -0.2003 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.88 | 84.90 | 950 | 531 | 1.7891 | 1.4920 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.88 | 84.90 | 4 | 531 | 0.0075 | -0.6850 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.88 | 84.90 | 884 | 531 | 1.6648 | 1.4251 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 14.58 | 84.90 | 480 | 663 | 0.7235 | 0.7933 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 14.58 | 84.90 | 959 | 663 | 1.4456 | 1.2646 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 14.58 | 84.90 | 1 | 663 | 0.0015 | -0.7763 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 14.58 | 84.90 | 962 | 663 | 1.4501 | 1.2670 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 16.29 | 84.90 | 823 | 766 | 1.0732 | 1.0450 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 16.29 | 84.90 | 1026 | 766 | 1.3379 | 1.1920 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 16.29 | 84.90 | 2 | 766 | 0.0026 | -0.6929 | MN20160318_Q02 | H18 |